AGS Transact Technologies Faces Significant Challenges Amidst Declining Stock Performance
AGS Transact Technologies has reached a new 52-week low, reflecting significant challenges in its stock performance. The company reported a substantial decline in net sales and operating losses, with a low return on equity. Over the past year, its stock value has decreased dramatically, underperforming market benchmarks.
AGS Transact Technologies, a microcap player in the IT software industry, has reached a new 52-week low of Rs. 10.89 today, marking a significant decline in its stock performance. The company has faced a challenging period, with its stock underperforming the sector by 3.33% and experiencing a consecutive fall for the last 21 days, resulting in a staggering 65.77% drop in returns during this timeframe.Financial metrics reveal a troubling picture for AGS Transact. The company reported a drastic 40.4% decline in net sales and has faced operating losses, contributing to a weak long-term fundamental strength. Its debt to EBITDA ratio stands at 3.33 times, indicating a low ability to service debt. Additionally, the return on equity averages a mere 0.57%, reflecting low profitability.
Over the past year, AGS Transact Technologies has seen a dramatic 84.02% decrease in stock value, significantly underperforming the Sensex, which has gained 4.65% in the same period. The technical indicators suggest a bearish trend, with the stock trading below all key moving averages. Overall, AGS Transact Technologies is navigating a challenging landscape marked by negative operating profits and consistent underperformance against market benchmarks.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
